A germline mutation in the BRCA1 3’UTR predicts Stage IV breast cancer

BACKGROUND: A germline, variant in the BRCA1 3’UTR (rs8176318) was previously shown to predict breast and ovarian cancer risk in women from high-risk families, as well as increased risk of triple negative breast cancer. Here, we tested the hypothesis that this variant predicts tumor biology, like ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorairaj, Jemima J, Salzman, David W, Wall, Deirdre, Rounds, Tiffany, Preskill, Carina, Sullivan, Catherine AW, Lindner, Robert, Curran, Catherine, Lezon-Geyda, Kim, McVeigh, Terri, Harris, Lyndsay, Newell, John, Kerin, Michael J, Wood, Marie, Miller, Nicola, Weidhaas, Joanne B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059881/
https://www.ncbi.nlm.nih.gov/pubmed/24915755
http://dx.doi.org/10.1186/1471-2407-14-421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059881/
https://www.ncbi.nlm.nih.gov/pubmed/24915755
http://dx.doi.org/10.1186/1471-2407-14-421

Ejemplares similares